Plaque Psoriasis Treatment | VTAMA® (tapinarof) cream, 1%

VTAMA CREAM IS A ONCE-DAILY, STEROID-FREE TREATMENT FOR ADULTS WITH PLAQUE PSORIASIS^1,2

VTAMA® (tapinarof) cream, 1% is a first-in-class topical treatment for adults with plaque psoriasis. It’s an Aryl hydrocarbon Receptor (AhR) agonist that could change the approach to plaque psoriasis treatment.^1,3

Prescribed branded topical treatment for plaque psoriasis in adults*

6x the Efficacy vs Vehicle

In two 12-week pivotal studies, the Physician Global Assessment (PGA) success^† rate was 36% and 40% for patients using VTAMA cream vs 6% and 6% for patients on vehicle.¹
Favorable Safety and Tolerability

In clinical studies, VTAMA cream showed a favorable and consistent safety profile and was well tolerated, even on sensitive areas of skin.^4-6
~4 Month Off-Treatment Effect

In an open-label, long-term extension study, the median time to first disease worsening (defined as PGA≥2 [mild]) was 114 days (95% CI: 85, 142).¹

^†PGA success: PGA score of 0 or 1 and ≥2-grade improvement from baseline at week 12.

what patients from clinical studies
said about VTAMA cream

VTAMA® Cream and Droplet — ~90% of patients said VTAMA cream is easy to apply, non-greasy, and absorbs quickly⁷

Checkmark next to VTAMA® Cream — 84% of patients would recommend VTAMA cream to others if available⁷

Thumbs-up icon — 83% of patients said they would use VTAMA cream again or continue to use treatment⁷

What would you like to see next?